Pinz Capital Management, LP Oncocyte Corp Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.53 - $5.89 $76,601 - $127,813
-21,700 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$3.77 - $6.0 $4,524 - $7,200
-1,200 Reduced 5.24%
21,700 $125,000
Q1 2021

May 17, 2021
BUY
$2.39 - $6.5 $54,731 - $148,850
22,900 New
22,900 $119,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $305M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email